Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal. [electronic resource]
Producer: 20171106Description: 566 p. digitalISSN:- 1471-2334
- Antibiotic Prophylaxis
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hepatitis B -- drug therapy
- Hepatitis B Antibodies -- blood
- Hepatitis B Surface Antigens -- blood
- Hepatitis B virus -- immunology
- Humans
- Immunocompromised Host
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.